| # | Drug | Count |
|---|---|---|
| 0 | CONJUGATED ESTROGENS | 133 |
| 1 | ESTROGENS, CONJUGATED | 133 |
| 2 | MEDROXYPROGESTERONE ACETATE | 102 |
| 3 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 90 |
| 4 | ESTRADIOL | 15 |
| 5 | TAMOXIFEN CITRATE | 10 |
| 6 | ANASTROZOLE | 7 |
| 7 | ESTRADIOL GEL 0.1% | 6 |
| 8 | ESTRADIOL TRANSDERMAL | 6 |
| 9 | ESTRADIOL, | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 2 | 0.0054 |
| 1 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 2 | 0.0054 |
| 2 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 90 | 0.0038 |
| 3 | CONJUGATED ESTROGENS | 133 | 0.0023 |
| 4 | ESTROGENS, CONJUGATED | 133 | 0.0022 |
| 5 | TAMOXIFEN CITRATE | 10 | 0.0017 |
| 6 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| 7 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 2 | 0.0009 |
| 8 | NORETHINDRONE | 3 | 0.0005 |
| 9 | FLUOROMETHOLONE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 165 |
| 1 | Aromatase Inhibitor [EPC] | 15 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 6 |
| 3 | Progesterone [EPC] | 6 |
| 4 | Alkylating Drug [EPC] | 2 |
| 5 | Androgen [EPC] | 2 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| 7 | Aldosterone Antagonist [EPC] | 1 |
| 8 | Bile Acid [EPC] | 1 |
| 9 | Calcium [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen [EPC] | 165 | 0.0009 |
| 1 | Progesterone [EPC] | 6 | 0.0003 |
| 2 | Aromatase Inhibitor [EPC] | 15 | 0.0001 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 6 | 0.0001 |
| 4 | Androgen [EPC] | 2 | 0.0001 |
| 5 | Bile Acid [EPC] | 1 | 0.0000 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Parathyroid Hormone Analog [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |